Login
Home / 009290.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kwang Dong Pharmaceutical Co., Ltd.

₩6370 +$520.00 (+8.89%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩6380
Day Range
₩6330₩6440
Year Range
₩5150₩12800
Market Cap
316.34B
AVG Volume
193.68K
Trailing/Forward PE
12.6/12.09
PEG ratio
-9.62
Dividend Yield
1.57%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0200B400B600B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
05B10B15B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
05B10B15B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
-100B-50B050B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-40B-20B020B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
020040060024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
-25B025B50B75B100BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
0100B200B300B400BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%5%10%15%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%1%2%3%4%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0255075100Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21Dec 22Dec 23Mar 25Mar 26
Book Value Per Share (KRW)
0500010000150002000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
0500B1T1.5T24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
5101520med 8.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-60%-40%-20%0%20%40%med -2.99%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.10.150.20.25med 0.15Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
24681012med 4.84Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
0102030med 5.52Sep 23Jan 24Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
0.30.40.50.60.7med 0.38Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Kwang Dong Pharmaceutical Co., Ltd.
009290.KS
Stockpicker

Video analysis: 009290.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.